146 related articles for article (PubMed ID: 9705248)
1. Characterization of mouse lines transgenic with the human poliovirus receptor gene.
Deatly AM; Taffs RE; McAuliffe JM; Nawoschik SP; Coleman JW; McMullen G; Weeks-Levy C; Johnson AJ; Racaniello VR
Microb Pathog; 1998 Jul; 25(1):43-54. PubMed ID: 9705248
[TBL] [Abstract][Full Text] [Related]
2. Poliomyelitis in intraspinally inoculated poliovirus receptor transgenic mice.
Deatly AM; Coleman JW; McMullen G; McAuliffe JM; Jayarama V; Cupo A; Crowley JC; McWilliams T; Taffs RE
Virology; 1999 Mar; 255(2):221-7. PubMed ID: 10069947
[TBL] [Abstract][Full Text] [Related]
3. Efficient delivery of circulating poliovirus to the central nervous system independently of poliovirus receptor.
Yang WX; Terasaki T; Shiroki K; Ohka S; Aoki J; Tanabe S; Nomura T; Terada E; Sugiyama Y; Nomoto A
Virology; 1997 Mar; 229(2):421-8. PubMed ID: 9126254
[TBL] [Abstract][Full Text] [Related]
4. Poliovirus-sensitive transgenic mice as a new animal model.
Koike S; Horie H; Sato Y; Ise I; Taya C; Nomura T; Yoshioka I; Yonekawa H; Nomoto A
Dev Biol Stand; 1993; 78():101-7. PubMed ID: 8388819
[TBL] [Abstract][Full Text] [Related]
5. Characterization of three different transgenic mouse lines that carry human poliovirus receptor gene--influence of the transgene expression on pathogenesis.
Koike S; Taya C; Aoki J; Matsuda Y; Ise I; Takeda H; Matsuzaki T; Amanuma H; Yonekawa H; Nomoto A
Arch Virol; 1994; 139(3-4):351-63. PubMed ID: 7832641
[TBL] [Abstract][Full Text] [Related]
6. Poliovirus attenuation and pathogenesis in a transgenic mouse model for poliomyelitis.
Racaniello VR; Ren R; Bouchard M
Dev Biol Stand; 1993; 78():109-16. PubMed ID: 8388820
[TBL] [Abstract][Full Text] [Related]
7. Development of a neurovirulent testing system for oral poliovirus vaccine with transgenic mice.
Levenbook I; Nomura T
Lab Anim Sci; 1997 Apr; 47(2):118-20. PubMed ID: 9150487
[TBL] [Abstract][Full Text] [Related]
8. Mouse homolog of poliovirus receptor-related gene 2 product, mPRR2, mediates homophilic cell aggregation.
Aoki J; Koike S; Asou H; Ise I; Suwa H; Tanaka T; Miyasaka M; Nomoto A
Exp Cell Res; 1997 Sep; 235(2):374-84. PubMed ID: 9299162
[TBL] [Abstract][Full Text] [Related]
9. A poliomyelitis model through mucosal infection in transgenic mice bearing human poliovirus receptor, TgPVR21.
Nagata N; Iwasaki T; Ami Y; Sato Y; Hatano I; Harashima A; Suzaki Y; Yoshii T; Hashikawa T; Sata T; Horiuchi Y; Koike S; Kurata T; Nomoto A
Virology; 2004 Mar; 321(1):87-100. PubMed ID: 15033568
[TBL] [Abstract][Full Text] [Related]
10. Retrograde transport of intact poliovirus through the axon via the fast transport system.
Ohka S; Yang WX; Terada E; Iwasaki K; Nomoto A
Virology; 1998 Oct; 250(1):67-75. PubMed ID: 9770421
[TBL] [Abstract][Full Text] [Related]
11. Neurovirulence test for oral live poliovaccines using poliovirus-sensitive transgenic mice.
Abe S; Ota Y; Koike S; Kurata T; Horie H; Nomura T; Hashizume S; Nomoto A
Virology; 1995 Feb; 206(2):1075-83. PubMed ID: 7856082
[TBL] [Abstract][Full Text] [Related]
12. [The observation on infection of trasgenic mice (PVR Tg21) with polioviruses type 3].
Guo R; Chen S; Luo Q; Wang Q
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Feb; 20(1):70-5. PubMed ID: 11367738
[TBL] [Abstract][Full Text] [Related]
13. Expression of the human poliovirus receptor/CD155 gene during development of the central nervous system: implications for the pathogenesis of poliomyelitis.
Gromeier M; Solecki D; Patel DD; Wimmer E
Virology; 2000 Aug; 273(2):248-57. PubMed ID: 10915595
[TBL] [Abstract][Full Text] [Related]
14. A poliovirus-susceptible transgenic mouse model as a possible replacement for the monkey neurovirulence test of oral poliovirus vaccine.
Dragunsky E; Taffs R; Chernokhvostova Y; Nomura T; Hioki K; Gardner D; Norwood L; Levenbook I
Biologicals; 1996 Jun; 24(2):77-86. PubMed ID: 8889053
[TBL] [Abstract][Full Text] [Related]
15. Studies on neurovirulence in poliovirus-sensitive transgenic mice and cynomolgus monkeys for the different temperature-sensitive viruses derived from the Sabin type 3 virus.
Abe S; Ota Y; Doi Y; Nomoto A; Nomura T; Chumakov KM; Hashizume S
Virology; 1995 Jun; 210(1):160-6. PubMed ID: 7793068
[TBL] [Abstract][Full Text] [Related]
16. Comparison of neuropathogenicity of poliovirus in two transgenic mouse strains expressing human poliovirus receptor with different distribution patterns.
Ida-Hosonuma M; Iwasaki T; Taya C; Sato Y; Li J; Nagata N; Yonekawa H; Koike S
J Gen Virol; 2002 May; 83(Pt 5):1095-1105. PubMed ID: 11961264
[TBL] [Abstract][Full Text] [Related]
17. Expression of mutated poliovirus receptors in human neuroblastoma cells persistently infected with poliovirus.
Pavio N; Couderc T; Girard S; Sgro JY; Blondel B; Colbère-Garapin F
Virology; 2000 Sep; 274(2):331-42. PubMed ID: 10964776
[TBL] [Abstract][Full Text] [Related]
18. Growth phenotypes and biosafety profiles in poliovirus-receptor transgenic mice of recombinant oncolytic polio/human rhinoviruses.
Cello J; Toyoda H; Dejesus N; Dobrikova EY; Gromeier M; Wimmer E
J Med Virol; 2008 Feb; 80(2):352-9. PubMed ID: 18098139
[TBL] [Abstract][Full Text] [Related]
19. Transgenic PVR Tg-1 mice for testing of poliovirus type 3 neurovirulence: comparison with monkey test.
Dragunsky E; Gardner D; Taffs R; Levenbook I
Biologicals; 1993 Sep; 21(3):233-7. PubMed ID: 8117436
[TBL] [Abstract][Full Text] [Related]
20. One hundred years of poliovirus pathogenesis.
Racaniello VR
Virology; 2006 Jan; 344(1):9-16. PubMed ID: 16364730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
